FDA has granted approval to GENUS for generic medication associated with ANDA207108, marking a continuation of the company's push into specified therapeutic markets. This approval is expected to bolster GENUS's revenue streams and maintain its competitive positioning within the generic sector without the need for additional generic ingredients.